These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 23398329

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.
    Yap BK, Buckle MJ, Doughty SW.
    J Mol Model; 2012 Aug; 18(8):3639-55. PubMed ID: 22354276
    [Abstract] [Full Text] [Related]

  • 23. Homology modeling of human muscarinic acetylcholine receptors.
    Thomas T, McLean KC, McRobb FM, Manallack DT, Chalmers DK, Yuriev E.
    J Chem Inf Model; 2014 Jan 27; 54(1):243-53. PubMed ID: 24328076
    [Abstract] [Full Text] [Related]

  • 24. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.
    Loo JSE, Emtage AL, Ng KW, Yong ASJ, Doughty SW.
    J Mol Graph Model; 2018 Mar 27; 80():38-47. PubMed ID: 29306746
    [Abstract] [Full Text] [Related]

  • 25. GPCR homology model template selection benchmarking: Global versus local similarity measures.
    Castleman PN, Sears CK, Cole JA, Baker DL, Parrill AL.
    J Mol Graph Model; 2019 Jan 27; 86():235-246. PubMed ID: 30390544
    [Abstract] [Full Text] [Related]

  • 26. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM.
    PLoS Comput Biol; 2017 Nov 27; 13(11):e1005819. PubMed ID: 29131821
    [Abstract] [Full Text] [Related]

  • 27. Homology model-assisted elucidation of binding sites in GPCRs.
    Levit A, Barak D, Behrens M, Meyerhof W, Niv MY.
    Methods Mol Biol; 2012 Nov 27; 914():179-205. PubMed ID: 22976029
    [Abstract] [Full Text] [Related]

  • 28. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
    Ekhteiari Salmas R, Serhat Is Y, Durdagi S, Stein M, Yurtsever M.
    J Biomol Struct Dyn; 2018 Aug 27; 36(10):2668-2677. PubMed ID: 28805144
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
    Zhang L, Shih AY, Yang XV, Kuei C, Wu J, Deng X, Mani NS, Mirzadegan T, Sun S, Lovenberg TW, Liu C.
    Mol Pharmacol; 2012 Dec 27; 82(6):1094-103. PubMed ID: 22930711
    [Abstract] [Full Text] [Related]

  • 31. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O, Kieć-Kononowicz K.
    J Comput Chem; 2009 Jan 15; 30(1):14-32. PubMed ID: 18496794
    [Abstract] [Full Text] [Related]

  • 32. Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.
    Platania CB, Salomone S, Leggio GM, Drago F, Bucolo C.
    PLoS One; 2012 Jan 15; 7(9):e44316. PubMed ID: 22970199
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.
    Dziedzicka-Wasylewska M, Faron-Górecka A, Górecki A, Kuśemider M.
    Pharmacol Rep; 2008 Jan 15; 60(5):581-7. PubMed ID: 19066405
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1/D3 heterodimer.
    Hounsou C, Margathe JF, Oueslati N, Belhocine A, Dupuis E, Thomas C, Mann A, Ilien B, Rognan D, Trinquet E, Hibert M, Pin JP, Bonnet D, Durroux T.
    ACS Chem Biol; 2015 Feb 20; 10(2):466-74. PubMed ID: 25350273
    [Abstract] [Full Text] [Related]

  • 37. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
    Tang Y, Chen KX, Jiang HL, Jin GZ, Ji RY.
    Zhongguo Yao Li Xue Bao; 1996 Jan 20; 17(1):8-12. PubMed ID: 8737443
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T, Lenselink B, Pala D, McRobb F, Repasky M, Sherman W.
    Methods Mol Biol; 2015 Jan 20; 1335():251-76. PubMed ID: 26260606
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.